Combined use of <sup>177</sup> Lu‐DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well‐differentiated neuroendocrine tumors: A preclinical study-Reference-Cited by-同舟云学术

Combined use of ¹⁷⁷ Lu‐DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well‐differentiated neuroendocrine tumors: A preclinical study

Published:2022-03-19 Issue:4 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Fu Jingjing¹,Qiu Fan¹,Stolniceanu Cati Raluca²³,Yu Fei¹,Zang Shiming¹,Xiang Yili⁴,Huang Yue⁵,Matovic Milovan⁶⁷,Stefanescu Cipriana²³,Tang Qiyun⁸,Wang Feng¹^ORCID

Affiliation:

1. Department of Nuclear Medicine Nanjing First Hospital Nanjing Medical University Nanjing China

2. Division of Nuclear Medicine Department of Biophysics and Medical Physics Grigore T. Popa University of Medicine and Pharmacy Iasi Romania

3. Nuclear Medicine Clinic St. Spiridon Hospital Iasi Romania

4. Department of Nuclear Medicine Taizhou First People Hospital Nanjing University of Traditional Chinese Medicine Nanjing China

5. Department of Pathology Nanjing First Hospital Nanjing Medical University Nanjing China

6. Clinical Center Kragujevac Center for Nuclear Medicine Kragujevac Serbia

7. Faculty of Medical Sciences University of Kragujevac Kragujevac Serbia

8. Department of Geriatric Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13109

Reference44 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications

4. Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry;Kollar A;Swiss Med Wkly,2020

5. Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics;EJNMMI Research;2024-08-13

2. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair;Pharmaceutics;2023-12-12

3. Multi-Radionuclide in Vivo Imaging of Solid Tumors in Small Laboratory Animals for Experimental Oncology;Meditsinskaya Fizika;2023-10-02

4. Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies;International Journal of Molecular Sciences;2023-02-10

5. Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy;International Journal of Molecular Sciences;2022-10-15